CD8A and neoplasm: Thus, CAN-2409 + prodrug treatment results in enhanced proliferation of CD8+ T cells within the remodeled TME, and this is accompanied by differentiation into an intermediate-exhausted state that retains key effector functions contributing to increased tumor control.